Annual Shareholders Equity
$14.80 B
+$1.40 B+10.46%
31 December 2023
Summary:
Biogen annual stockholders equity is currently $14.80 billion, with the most recent change of +$1.40 billion (+10.46%) on 31 December 2023. During the last 3 years, it has risen by +$4.10 billion (+38.31%). BIIB annual shareholders equity is now at all-time high.BIIB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$16.36 B
+$469.80 M+2.96%
30 September 2024
Summary:
Biogen quarterly stockholders equity is currently $16.36 billion, with the most recent change of +$469.80 million (+2.96%) on 30 September 2024. Over the past year, it has increased by +$1.88 billion (+12.95%). BIIB quarterly shareholders equity is now at all-time high.BIIB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BIIB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +10.5% | +12.9% |
| 3 y3 years | +38.3% | +56.9% |
| 5 y5 years | +13.5% | +16.9% |
BIIB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.3% | at high | +56.9% |
| 5 y | 5 years | at high | +38.3% | at high | +56.9% |
| alltime | all time | at high | >+9999.0% | at high | >+9999.0% |
Biogen Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $16.36 B(+3.0%) |
| June 2024 | - | $15.89 B(+4.4%) |
| Mar 2024 | - | $15.21 B(+2.8%) |
| Dec 2023 | $14.80 B(+10.5%) | $14.80 B(+2.2%) |
| Sept 2023 | - | $14.48 B(+0.1%) |
| June 2023 | - | $14.47 B(+4.9%) |
| Mar 2023 | - | $13.80 B(+3.0%) |
| Dec 2022 | $13.40 B(+23.0%) | $13.40 B(+4.9%) |
| Sept 2022 | - | $12.78 B(+7.6%) |
| June 2022 | - | $11.87 B(+5.6%) |
| Mar 2022 | - | $11.24 B(+3.2%) |
| Dec 2021 | $10.90 B(+1.8%) | $10.90 B(+4.5%) |
| Sept 2021 | - | $10.43 B(-3.0%) |
| June 2021 | - | $10.75 B(+0.7%) |
| Mar 2021 | - | $10.68 B(-0.2%) |
| Dec 2020 | $10.70 B(-19.8%) | $10.70 B(-0.5%) |
| Sept 2020 | - | $10.76 B(-4.9%) |
| June 2020 | - | $11.31 B(-9.9%) |
| Mar 2020 | - | $12.55 B(-6.0%) |
| Dec 2019 | $13.34 B(+2.3%) | $13.34 B(-4.7%) |
| Sept 2019 | - | $14.00 B(+8.1%) |
| June 2019 | - | $12.95 B(-6.3%) |
| Mar 2019 | - | $13.83 B(+6.1%) |
| Dec 2018 | $13.04 B(+3.4%) | $13.04 B(-5.3%) |
| Sept 2018 | - | $13.77 B(+12.3%) |
| June 2018 | - | $12.26 B(-12.8%) |
| Mar 2018 | - | $14.05 B(+11.4%) |
| Dec 2017 | $12.61 B(+3.9%) | $12.61 B(-1.9%) |
| Sept 2017 | - | $12.86 B(+11.0%) |
| June 2017 | - | $11.59 B(+0.9%) |
| Mar 2017 | - | $11.48 B(-5.4%) |
| Dec 2016 | $12.14 B(+29.5%) | $12.14 B(+0.2%) |
| Sept 2016 | - | $12.12 B(+6.3%) |
| June 2016 | - | $11.40 B(+10.4%) |
| Mar 2016 | - | $10.33 B(+10.2%) |
| Dec 2015 | $9.37 B(-13.3%) | $9.37 B(-11.3%) |
| Sept 2015 | - | $10.57 B(-15.9%) |
| June 2015 | - | $12.57 B(+7.8%) |
| Mar 2015 | - | $11.67 B(+7.9%) |
| Dec 2014 | $10.81 B(+25.4%) | $10.81 B(+3.7%) |
| Sept 2014 | - | $10.43 B(+9.1%) |
| June 2014 | - | $9.56 B(+4.6%) |
| Mar 2014 | - | $9.14 B(+6.0%) |
| Dec 2013 | $8.62 B(+23.8%) | $8.62 B(+6.1%) |
| Sept 2013 | - | $8.13 B(+2.8%) |
| June 2013 | - | $7.90 B(+7.7%) |
| Mar 2013 | - | $7.34 B(+5.4%) |
| Dec 2012 | $6.96 B(+8.3%) | $6.96 B(+4.5%) |
| Sept 2012 | - | $6.66 B(+6.2%) |
| June 2012 | - | $6.27 B(-0.6%) |
| Mar 2012 | - | $6.31 B(-1.9%) |
| Dec 2011 | $6.43 B(+19.1%) | $6.43 B(+3.2%) |
| Sept 2011 | - | $6.23 B(+4.2%) |
| June 2011 | - | $5.98 B(+6.7%) |
| Mar 2011 | - | $5.60 B(+3.8%) |
| Dec 2010 | $5.40 B(-13.3%) | $5.40 B(+7.3%) |
| Sept 2010 | - | $5.03 B(-2.7%) |
| June 2010 | - | $5.17 B(-12.5%) |
| Mar 2010 | - | $5.91 B(-5.0%) |
| Dec 2009 | $6.22 B(+7.2%) | $6.22 B(-5.2%) |
| Sept 2009 | - | $6.56 B(+5.7%) |
| June 2009 | - | $6.21 B(+3.8%) |
| Mar 2009 | - | $5.99 B(+3.1%) |
| Dec 2008 | $5.81 B(+4.9%) | $5.81 B(+0.7%) |
| Sept 2008 | - | $5.77 B(+4.4%) |
| June 2008 | - | $5.52 B(-0.2%) |
| Mar 2008 | - | $5.53 B(-0.0%) |
| Dec 2007 | $5.53 B(-22.6%) | $5.53 B(+10.8%) |
| Sept 2007 | - | $4.99 B(+7.7%) |
| June 2007 | - | $4.64 B(-36.9%) |
| Mar 2007 | - | $7.35 B(+2.8%) |
| Dec 2006 | $7.15 B | $7.15 B(+3.7%) |
| Sept 2006 | - | $6.89 B(-1.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2006 | - | $7.01 B(-1.9%) |
| Mar 2006 | - | $7.14 B(+3.4%) |
| Dec 2005 | $6.91 B(+1.2%) | $6.91 B(+1.6%) |
| Sept 2005 | - | $6.80 B(+0.8%) |
| June 2005 | - | $6.75 B(-0.5%) |
| Mar 2005 | - | $6.78 B(-0.7%) |
| Dec 2004 | $6.83 B(-3.2%) | $6.83 B(+1.7%) |
| Sept 2004 | - | $6.71 B(-3.2%) |
| June 2004 | - | $6.93 B(-3.7%) |
| Mar 2004 | - | $7.20 B(+2.0%) |
| Dec 2003 | $7.05 B(+535.6%) | $7.05 B(+296.9%) |
| Sept 2003 | - | $1.78 B(+3.9%) |
| June 2003 | - | $1.71 B(+5.7%) |
| Mar 2003 | - | $1.62 B(+45.9%) |
| Dec 2002 | $1.11 B(-17.7%) | $1.11 B(-28.1%) |
| Sept 2002 | - | $1.54 B(+4.1%) |
| June 2002 | - | $1.48 B(+4.0%) |
| Mar 2002 | - | $1.43 B(+5.7%) |
| Dec 2001 | $1.35 B(+21.9%) | $1.35 B(+4.4%) |
| Sept 2001 | - | $1.29 B(+2.5%) |
| June 2001 | - | $1.26 B(+6.8%) |
| Mar 2001 | - | $1.18 B(+6.7%) |
| Dec 2000 | $1.11 B(+13.0%) | $1.11 B(+4.3%) |
| Sept 2000 | - | $1.06 B(+5.8%) |
| June 2000 | - | $1.00 B(-1.4%) |
| Mar 2000 | - | $1.02 B(+3.9%) |
| Dec 1999 | $979.53 M(+36.3%) | $979.53 M(+3.9%) |
| Sept 1999 | - | $942.50 M(+8.7%) |
| June 1999 | - | $866.90 M(+2.2%) |
| Mar 1999 | - | $848.60 M(+18.1%) |
| Dec 1998 | $718.61 M(+34.0%) | $718.61 M(+7.4%) |
| Sept 1998 | - | $668.80 M(+8.0%) |
| June 1998 | - | $619.50 M(+7.7%) |
| Mar 1998 | - | $575.10 M(+7.2%) |
| Dec 1997 | $536.29 M(+10.7%) | $536.29 M(-8.8%) |
| Sept 1997 | - | $587.90 M(+5.2%) |
| June 1997 | - | $558.90 M(+4.3%) |
| Mar 1997 | - | $535.80 M(+10.6%) |
| Dec 1996 | $484.37 M(+26.5%) | $484.37 M(+5.0%) |
| Sept 1996 | - | $461.10 M(+23.2%) |
| June 1996 | - | $374.20 M(-1.9%) |
| Mar 1996 | - | $381.30 M(-0.4%) |
| Dec 1995 | $382.98 M(+16.1%) | $382.98 M(+6.8%) |
| Sept 1995 | - | $358.70 M(+4.8%) |
| June 1995 | - | $342.40 M(+1.7%) |
| Mar 1995 | - | $336.60 M(+2.0%) |
| Dec 1994 | $329.93 M(+1.5%) | $329.93 M(+2.9%) |
| Sept 1994 | - | $320.70 M(-6.2%) |
| June 1994 | - | $342.00 M(+1.9%) |
| Mar 1994 | - | $335.50 M(+3.2%) |
| Dec 1993 | $325.20 M(+14.1%) | $325.20 M(+2.5%) |
| Sept 1993 | - | $317.30 M(+4.2%) |
| June 1993 | - | $304.50 M(+2.4%) |
| Mar 1993 | - | $297.40 M(+4.4%) |
| Dec 1992 | $285.00 M(+19.2%) | $285.00 M(+12.9%) |
| Sept 1992 | - | $252.40 M(+4.4%) |
| June 1992 | - | $241.70 M(+0.6%) |
| Mar 1992 | - | $240.30 M(+0.5%) |
| Dec 1991 | $239.00 M(+64.0%) | $239.00 M(+56.7%) |
| Sept 1991 | - | $152.50 M(+2.3%) |
| June 1991 | - | $149.00 M(+0.8%) |
| Mar 1991 | - | $147.80 M(+1.4%) |
| Dec 1990 | $145.70 M(+4.7%) | $145.70 M(+1.0%) |
| Sept 1990 | - | $144.20 M(+1.8%) |
| June 1990 | - | $141.60 M(+1.2%) |
| Mar 1990 | - | $139.90 M(+0.5%) |
| Dec 1989 | $139.20 M(+104.7%) | $139.20 M(+1.3%) |
| Sept 1989 | - | $137.40 M(+102.1%) |
| Dec 1988 | $68.00 M(+0.1%) | $68.00 M(+0.1%) |
| Dec 1987 | $67.90 M(-24.0%) | $67.90 M(-24.0%) |
| Dec 1986 | $89.30 M(+19.2%) | $89.30 M(+19.2%) |
| Dec 1985 | $74.90 M(-18.5%) | $74.90 M(-18.5%) |
| Dec 1984 | $91.90 M | $91.90 M |
FAQ
- What is Biogen annual stockholders equity?
- What is the all time high annual shareholders equity for Biogen?
- What is Biogen annual shareholders equity year-on-year change?
- What is Biogen quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Biogen?
- What is Biogen quarterly shareholders equity year-on-year change?
What is Biogen annual stockholders equity?
The current annual shareholders equity of BIIB is $14.80 B
What is the all time high annual shareholders equity for Biogen?
Biogen all-time high annual stockholders equity is $14.80 B
What is Biogen annual shareholders equity year-on-year change?
Over the past year, BIIB annual stockholders equity has changed by +$1.40 B (+10.46%)
What is Biogen quarterly stockholders equity?
The current quarterly shareholders equity of BIIB is $16.36 B
What is the all time high quarterly shareholders equity for Biogen?
Biogen all-time high quarterly stockholders equity is $16.36 B
What is Biogen quarterly shareholders equity year-on-year change?
Over the past year, BIIB quarterly stockholders equity has changed by +$1.88 B (+12.95%)